BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22074660)

  • 1. Chromatin remodelling protein SMAR1 inhibits p53 dependent transactivation by regulating acetyl transferase p300.
    Sinha S; Malonia SK; Mittal SP; Mathai J; Pal JK; Chattopadhyay S
    Int J Biochem Cell Biol; 2012 Jan; 44(1):46-52. PubMed ID: 22074660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skp2 suppresses p53-dependent apoptosis by inhibiting p300.
    Kitagawa M; Lee SH; McCormick F
    Mol Cell; 2008 Feb; 29(2):217-31. PubMed ID: 18243116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 target gene SMAR1 is dysregulated in breast cancer: its role in cancer cell migration and invasion.
    Singh K; Mogare D; Giridharagopalan RO; Gogiraju R; Pande G; Chattopadhyay S
    PLoS One; 2007 Aug; 2(7):e660. PubMed ID: 17668048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor SMAR1 downregulates Cytokeratin 8 expression by displacing p53 from its cognate site.
    Pavithra L; Singh S; Sreenath K; Chattopadhyay S
    Int J Biochem Cell Biol; 2009 Apr; 41(4):862-71. PubMed ID: 18822384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element.
    Sinha S; Malonia SK; Mittal SP; Singh K; Kadreppa S; Kamat R; Mukhopadhyaya R; Pal JK; Chattopadhyay S
    EMBO J; 2010 Feb; 29(4):830-42. PubMed ID: 20075864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region.
    Somasundaram K; El-Deiry WS
    Oncogene; 1997 Mar; 14(9):1047-57. PubMed ID: 9070653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin remodeling protein SMAR1 regulates NF-κB dependent Interleukin-8 transcription in breast cancer.
    Malonia SK; Yadav B; Sinha S; Lazennec G; Chattopadhyay S
    Int J Biochem Cell Biol; 2014 Oct; 55():220-6. PubMed ID: 25239884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling.
    Sreenath K; Pavithra L; Singh S; Sinha S; Dash PK; Siddappa NB; Ranga U; Mitra D; Chattopadhyay S
    Virology; 2010 Apr; 400(1):76-85. PubMed ID: 20153010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
    Thomas MC; Chiang CM
    Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p300/CBP acetyl transferases interact with and acetylate the nucleotide excision repair factor XPG.
    Tillhon M; Cazzalini O; Nardo T; Necchi D; Sommatis S; Stivala LA; Scovassi AI; Prosperi E
    DNA Repair (Amst); 2012 Oct; 11(10):844-52. PubMed ID: 22954786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
    Pavithra L; Mukherjee S; Sreenath K; Kar S; Sakaguchi K; Roy S; Chattopadhyay S
    J Mol Biol; 2009 May; 388(4):691-702. PubMed ID: 19303885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of NBS1 knockdown by small interfering RNA on the ionizing radiation-induced apoptosis in human lymphoblastoid cells with different p53 status.
    Zhang Y; Lim CU; Zhou J; Liber HH
    Toxicol Lett; 2007 Jun; 171(1-2):50-9. PubMed ID: 17537595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53.
    Sasaki T; Gan EC; Wakeham A; Kornbluth S; Mak TW; Okada H
    Genes Dev; 2007 Apr; 21(7):848-61. PubMed ID: 17403783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.
    Grönroos E; Terentiev AA; Punga T; Ericsson J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12165-70. PubMed ID: 15295102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice.
    Kaul R; Mukherjee S; Ahmed F; Bhat MK; Chhipa R; Galande S; Chattopadhyay S
    Int J Cancer; 2003 Feb; 103(5):606-15. PubMed ID: 12494467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetyltransferase p300 regulates NBS1-mediated DNA damage response.
    Jang ER; Choi JD; Lee JS
    FEBS Lett; 2011 Jan; 585(1):47-52. PubMed ID: 21108945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T-cell leukemia virus type-1-encoded protein HBZ represses p53 function by inhibiting the acetyltransferase activity of p300/CBP and HBO1.
    Wright DG; Marchal C; Hoang K; Ankney JA; Nguyen ST; Rushing AW; Polakowski N; Miotto B; Lemasson I
    Oncotarget; 2016 Jan; 7(2):1687-706. PubMed ID: 26625199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.